Please assess the completion status of the following clinical trial:

Trial Title: Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or Female; ages 18 to 80 years old~2. Receiving treatment at Cancer Treatment Centers of America~3. Receiving PN (either in the infusion center or at home)~4. Have existing hepatic dysfunction defined as Elevation of \> 3x the normal level of one or more of the following:Alkaline Phosphatase (ALP), Aspartate Aminotransferase (AST), or Alanine Aminotransferase ALT) and/or Bilirubin \> 2 mg/dl in the absence of biliary obstruction~5. Able to provide informed written consent~Exclusion Criteria:~1. Hypertriglyceridemia (triglycerides \[TG\] \> 400)~2. Allergy to fish or egg protein~3. Currently on therapeutic doses of Coumadin, heparin, or low molecular eight heparin~4. Hemodynamically unstable~5. Bilirubin \> 5 mg/dL~6. Documented liver metastases~7. Unstable diabetes with known diabetic ketoacidosis within 7 days of screening~8. Recent cardiac infarction (within 6 months) and taking plavix~9. Severe hemorrhagic disorders~10. Current anticoagulation therapy for deep venous thromboembolism or pulmonary embolism~11. Active sepsis~12. Undefined coma status~13. In patients with abnormal kidney function, renal insufficiency with calculated creatinine clearance \< 30 mL/min~14. Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Omegaven (compassionate use) (Type: EXPERIMENTAL): This is a compassionate use study. All participants will receive intravenous Omegaven (10% fish oil emulsion) with parenteral nutrition for 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).